Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure - A primary role of mechanical unloading underlying reverse remodeling

被引:159
作者
Barbone, A
Holmes, JW
Heerdt, PM
The', AHS
Naka, Y
Joshi, N
Daines, M
Marks, AR
Oz, MC
Burkhoff, D
机构
[1] Columbia Univ, Dept Med, New York, NY 10032 USA
[2] Columbia Univ, Dept Surg, New York, NY 10032 USA
[3] Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol & Crit Care Med, New York, NY USA
[5] Cornell Univ, Weill Med Coll, New York, NY USA
关键词
mechanics; remodeling; hemodynamics;
D O I
10.1161/hc3101.093903
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Left ventricular assist devices (LVAD) reverse ventricular, myocardial, and systemic abnormalities characteristic of severe heart failure (reverse remodeling). The relative contributions of hemodynamic unloading and normalized biochemical milieu to reverse remodeling are unknown. Methods and Results-Structural and functional characteristics were measured from 53 hearts of patients undergoing transplantation without LVAD support (medical support) and 33 hearts from patients receiving a median of 46 days of LVAD support (range, 8 to 360 days). Compared with medical support alone, patients receiving LVAD support for greater than or equal to 30 days had higher central venous pressures (11 +/-6 versus 8 +/-5 mmHg, P=0.04), lower pulmonary artery diastolic pressures (14 +/-9 versus 21 +/-9 mm Hg, P= 0.01), and higher cardiac outputs (5.1 +/-1.6 versus 3.7 +/-1.0 L/min, P <0.001). In LVAD versus transplantation hearts, V-30 (ex vivo volume yielding ventricular pressure of 30 min Hg was decreased in the left ventricle (LV) (179 +/- 75 versus 261 +/- 118 mL, P=0.005) but not in the right ventricle (RV) (140 +/- 59 versus 148 +/- 52 mL, P=NS). LV myocyte diameter decreased more significantly after LVAD support (17%, P= 0.05) than in the RV (11%, P=NS). Compared with transplantation, LVAD support increased normalized SERCA2a content in the LV (0.51 +/-0.26 versus 1.04 +/-0.34, P <0.001) but not in the RV (0.48 +/- 34 versus 0.67 +/-0.55, P=NS). Finally, LVAD support improved force-frequency relations of isolated superfused LV trabeculae (P=0.01) but not RV trabeculae. Conclusions-Reduction of hemodynamic load is a primary factor underlying several important features of reverse remodeling. These findings do not preclude a possible primary role of neurohomonal factors underlying other facets of reverse remodeling during LVAD support.
引用
收藏
页码:670 / 675
页数:6
相关论文
共 25 条
[1]   Renin-angiotensin-aldosterone system and myocardial fibrosis [J].
Brilla, CG .
CARDIOVASCULAR RESEARCH, 2000, 47 (01) :1-3
[2]   Molecular and cellular mechanisms of myocardial failure [J].
Colucci, WS .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (11A) :L15-L25
[3]   Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure [J].
Dipla, K ;
Mattiello, JA ;
Jeevanandam, V ;
Houser, SR ;
Margulies, KB .
CIRCULATION, 1998, 97 (23) :2316-2322
[4]   FIRST USE OF AN UNTETHERED, VENTED ELECTRIC LEFT-VENTRICULAR ASSIST DEVICE FOR LONG-TERM SUPPORT [J].
FRAZIER, OH .
CIRCULATION, 1994, 89 (06) :2908-2914
[5]   IMPROVED MORTALITY AND REHABILITATION OF TRANSPLANT CANDIDATES TREATED WITH A LONG-TERM IMPLANTABLE LEFT-VENTRICULAR ASSIST SYSTEM [J].
FRAZIER, OH ;
ROSE, EA ;
MCCARTHY, P ;
BURTON, NA ;
TECTOR, A ;
LEVIN, H ;
KAYNE, HL ;
POIRIER, VL ;
DASSE, KA .
ANNALS OF SURGERY, 1995, 222 (03) :327-338
[6]   Medical progress - Implantable left ventricular assist devices [J].
Goldstein, DJ ;
Oz, MC ;
Rose, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1522-1533
[7]   Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure [J].
Heerdt, PM ;
Holmes, JW ;
Cai, BL ;
Barbone, A ;
Madigan, JD ;
Reiken, S ;
Lee, DL ;
Oz, MC ;
Marks, AR ;
Burkhoff, D .
CIRCULATION, 2000, 102 (22) :2713-2719
[8]   Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy [J].
Hetzer, R ;
Müller, JH ;
Weng, YG ;
Loebe, M ;
Wallukat, G .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2000, 120 (05) :843-855
[9]   Mechanisms of disease - Signaling pathways for cardiac hypertrophy and failure [J].
Hunter, JJ ;
Chien, KR .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) :1276-1283
[10]   EFFECT OF THE IMPLANTABLE LEFT-VENTRICULAR ASSIST DEVICE ON NEUROENDOCRINE ACTIVATION IN HEART-FAILURE [J].
JAMES, KB ;
MCCARTHY, PM ;
THOMAS, JD ;
VARGO, R ;
HOBBS, RE ;
SAPP, S ;
BRAVO, E .
CIRCULATION, 1995, 92 (09) :191-195